Global Lab Automation In Genomics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

In this report, the Global Lab Automation In Genomics Market has been segmented by Equipment, End User, and Geography.

Global Lab Automation In Genomics Market, Segmentation by Equipment

The Global Lab Automation In Genomics Market has been segmented by Equipment into Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage and Retrieval Systems (AS/RS) and Vision Systems.

Automated Liquid Handlers
Automated Liquid Handlers are vital for precise and efficient liquid transfer in genomics laboratories. By significantly reducing manual pipetting errors and increasing throughput, they play a pivotal role in high-volume testing workflows. With approximately 35% market share, these systems lead the adoption of lab automation in genomics research and diagnostics.

Automated Plate Handlers
Automated Plate Handlers help streamline microplate movement between instruments, reducing manual labor and operational delays. These devices seamlessly integrate with other lab automation systems, optimizing lab efficiency. They represent roughly 20% of automation equipment usage in genomics laboratories.

Robotic Arms
Robotic Arms offer flexibility and precision in handling various lab procedures such as reagent addition, sample preparation, and equipment interfacing. By minimizing contamination risks and improving speed, they have become an essential component in genomic labs, comprising around 18% of the segment.

Automated Storage and Retrieval Systems (AS/RS)
Automated Storage and Retrieval Systems (AS/RS) provide secure, climate-controlled environments for storing genomic samples and reagents. These systems improve traceability, reduce human error, and ensure consistent sample integrity. They make up approximately 15% of the genomics lab automation market.

Vision Systems
Vision Systems play a crucial role in quality control by using advanced imaging technologies for real-time sample inspection. These systems help detect anomalies early, ensuring accuracy and consistency in genomic research. They account for about 12% of lab automation deployments in genomics.

Global Lab Automation In Genomics Market, Segmentation by End User

The Global Lab Automation In Genomics Market has been segmented by End User into Biotechnology and pharmaceutical companies ,Hospital and diagnostic laboratories Research and academic institutes ,Forensic laboratories ,Environmental and testing laboratories ,Food and beverage industry

Biotechnology and Pharmaceutical Companies
Biotechnology and pharmaceutical companies dominate the genomics lab automation market with approximately 40% share. These organizations rely on automation to drive drug discovery, reduce human error, and increase the speed and accuracy of genomic testing and analysis.

Hospital and Diagnostic Laboratories
Hospital and diagnostic laboratories make up about 25% of the market. Automation allows these facilities to conduct high-throughput genetic testing, improving turnaround times, reducing operational costs, and enhancing patient care through faster diagnostics.

Research and Academic Institutes
Research and academic institutes hold nearly 15% of the genomics automation market. These institutions utilize automation to conduct large-scale genomic research, streamline workflows, and collaborate across disciplines for scientific advancements.

Forensic Laboratories
Forensic laboratories represent roughly 8% of the market. Lab automation in forensics ensures high precision, reproducibility, and faster processing of DNA samples, which are crucial for law enforcement and judicial systems.

Environmental and Testing Laboratories
Environmental and testing laboratories account for around 7% of the end-user base. These labs use automated genomics solutions to monitor environmental samples, assess biodiversity, and ensure regulatory compliance in various industries.

Food and Beverage Industry
The food and beverage industry contributes about 5% to the genomics lab automation market. Automation is leveraged to perform genetic-based quality control, detect pathogens, and trace contamination sources to maintain product integrity and consumer safety.

Global Lab Automation In Genomics Market, Segmentation by Geography

In this report, the Global Lab Automation In Genomics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Lab Automation In Genomics Market Share (%), by Geographical Region, 2024

North America
North America dominates the global genomics lab automation market with an estimated 38% share. This leadership is supported by cutting-edge healthcare systems, strong research funding, and early adoption of advanced lab automation tools in both clinical and academic settings.

Europe
Europe holds approximately 27% of the global market. The region’s established biotechnology landscape, supportive regulatory environment, and emphasis on genomic innovation contribute significantly to the rising adoption of lab automation technologies.

Asia Pacific
Asia Pacific captures about 22% of the market, driven by rapid medical advancements, expanding biotech sectors, and growing government initiatives in genomics. Countries like China, India, and Japan are at the forefront of this regional growth.

Middle East and Africa
With roughly 7% market share, the Middle East and Africa are emerging as potential markets for genomics lab automation. Increasing healthcare investments and the push for modern diagnostic capabilities are helping to accelerate adoption.

Latin America
Latin America comprises nearly 6% of the market. The region is steadily increasing its adoption of lab automation as healthcare modernization, genomic testing initiatives, and demand for accurate diagnostics gain momentum.

This report provides an in depth analysis of various factors that impact the dynamics of Global Lab Automation In Genomics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers :

• Increasing Investment in Genomics and Drug Discovery

• Availability of Advanced and Affordable Technologies - The global lab automation in genomics market is experiencing robust growth, largely driven by the availability of advanced and affordable technologies. Automation has revolutionized genomics research by streamlining processes, increasing throughput, and enhancing reproducibility. With the advent of innovative technologies and tools, laboratories can now automate various tasks such as DNA sequencing, PCR, sample preparation, and data analysis.

  This surge in automation is attributed to the development of more cost-effective solutions, making advanced genomics technologies accessible to a wider range of researchers and institutions. Furthermore, the integration of robotics, artificial intelligence, and cloud computing has further enhanced the efficiency and scalability of automated genomics workflows. As a result, the global lab automation in genomics market is poised for continued growth as demand for high-throughput and standardized genomic analysis continues to rise.

Restraints :

• High Initial Setup Cost

• Lack of Awareness and Expertise - The global lab automation in genomics market has witnessed significant growth in recent years, driven by the increasing demand for efficient and high-throughput solutions in genomic research and analysis. However, one of the key challenges hindering its growth is the lack of awareness and expertise among researchers and laboratory personnel.

  Many researchers and laboratory professionals may not be fully aware of the capabilities and benefits of lab automation in genomics, leading to underutilization of these technologies. Additionally, the complexity of some automated systems may require specialized expertise for operation and maintenance, which could be lacking in some laboratories.

  Addressing this challenge requires concerted efforts from industry stakeholders, including manufacturers, research institutions, and regulatory bodies, to increase awareness and provide training programs to equip researchers and laboratory personnel with the necessary skills and knowledge. By improving awareness and expertise in lab automation in genomics, the market can unlock its full potential and accelerate advancements in genomic research and personalized medicine.

Opportunity :

• Growing Demand for Personalized Medicine

• Technological Advancements - The field of genomics has witnessed remarkable advancements in laboratory automation, revolutionizing the way genetic research and analysis are conducted. With the integration of cutting-edge technologies, such as robotics, artificial intelligence (AI), and high-throughput sequencing platforms, lab automation has become indispensable in genomics research.

  One key area of advancement lies in sample preparation, where automated systems can efficiently process large volumes of samples with high accuracy and reproducibility. These systems not only streamline workflows but also minimize human error, leading to more reliable results. Additionally, the incorporation of AI algorithms enhances data analysis, allowing researchers to extract valuable insights from vast genomic datasets more rapidly than ever before. This convergence of technology and genomics is driving innovation and accelerating discoveries in fields ranging from personalized medicine to agricultural genetics.

Key players in Global Lab Automation In Genomics Market include

• Thermo Fisher Scientific Inc
• Danaher Corporation / Beckman Coulter
• Hudson Robotics
• Becton

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis